Crescent Capital BDC, Inc. (FCRX)
For informational purposes only. Not financial advice.
Crescent Capital BDC, Inc. (FCRX) is a publicly traded company trading at $25.00 with a market cap of 926532725. It holds a cautious AI score of 47/100 based on fundamental, technical, and sentiment analysis.
Crescent Capital BDC, Inc. is a business development company (BDC) focusing on debt and equity investments in middle-market companies. They target growth, acquisitions, and recapitalization transactions, primarily through debt securities with equity components.
Company Overview
Crescent Capital BDC (FCRX) offers institutional investors a compelling opportunity to access the middle-market lending space, characterized by its focus on debt and equity investments, a high dividend yield of 12.71%, and a proven strategy of supporting growing businesses with capital for expansion and acquisitions.
Investment Thesis
Crescent Capital BDC presents a compelling investment opportunity due to its focus on the underserved middle-market lending space, offering attractive yields and potential capital appreciation. The company's strategy of investing in debt securities with equity components allows it to participate in the upside potential of its portfolio companies. With a current dividend yield of 12.71% and a profit margin of 23.5%, FCRX offers a significant income stream for investors. Key value drivers include the company's ability to source and manage investments in middle-market companies, its disciplined investment approach, and its experienced management team. Growth catalysts include the increasing demand for capital from middle-market companies, the potential for rising interest rates, which could increase the yield on its debt investments, and the company's ability to deploy capital into new investments. The company's P/E ratio of 14.82 suggests that it is reasonably valued relative to its earnings.
Key Highlights
- Market capitalization of $0.93 billion indicates a sizable presence in the business development company sector.
- P/E ratio of 14.82 suggests a reasonable valuation compared to its earnings.
- Profit margin of 23.5% reflects efficient operations and profitable investment strategies.
- Gross margin of 31.7% demonstrates the company's ability to generate revenue above its cost of goods sold.
- Dividend yield of 12.71% offers a substantial income stream for investors, highlighting its attractiveness as an income-generating investment.
Competitors
Strengths
- High dividend yield of 12.71% attracts income-seeking investors.
- Focus on the underserved middle-market lending space.
- Experienced management team with a proven track record.
- Disciplined investment approach with a focus on due diligence.
Weaknesses
- Exposure to credit risk from investments in middle-market companies.
- Sensitivity to interest rate fluctuations.
- Reliance on external financing to fund investments.
- Smaller market capitalization compared to larger BDCs.
Catalysts
- Upcoming: Potential for increased investment income as interest rates rise.
- Ongoing: Continued deployment of capital into new middle-market investments.
- Ongoing: Active management of portfolio companies to drive value creation.
- Upcoming: Strategic partnerships with private equity firms to enhance deal flow.
Risks
- Potential: Credit losses on investments in distressed companies.
- Ongoing: Sensitivity to economic downturns and market volatility.
- Potential: Increased competition from other BDCs and alternative lenders.
- Ongoing: Regulatory changes could negatively impact the BDC industry.
- Potential: Fluctuations in interest rates could affect investment yields.
Growth Opportunities
- Increased Investment in Healthcare Sector: The healthcare sector presents a significant growth opportunity for Crescent Capital BDC. With an aging population and increasing demand for healthcare services, middle-market healthcare companies require capital for expansion and innovation. By allocating more capital to this sector, FCRX can capitalize on this growing market, potentially increasing its returns and diversifying its portfolio. The healthcare market is projected to reach trillions of dollars in the coming years, offering a substantial runway for growth.
- Expansion into Outsourced Business Services: The outsourced business services sector is experiencing rapid growth as companies increasingly seek to streamline operations and reduce costs. Crescent Capital BDC can capitalize on this trend by investing in middle-market companies that provide outsourced services such as IT support, customer service, and human resources. This sector offers attractive returns and diversification benefits. The global outsourcing market is expected to reach hundreds of billions of dollars, providing ample opportunities for investment.
- Strategic Partnerships with Private Equity Firms: Forming strategic partnerships with private equity firms can provide Crescent Capital BDC with access to a broader range of investment opportunities and enhance its deal sourcing capabilities. By collaborating with private equity firms, FCRX can co-invest in middle-market companies and leverage the expertise and resources of its partners. These partnerships can lead to higher returns and increased deal flow. The private equity industry manages trillions of dollars in assets, offering a vast pool of potential investment opportunities.
- Increased Focus on Equity Investments: While Crescent Capital BDC primarily invests in debt securities, increasing its focus on equity investments can enhance its returns and provide exposure to the upside potential of its portfolio companies. By selectively investing in equity, FCRX can participate in the long-term growth of its portfolio companies and generate capital gains. This strategy requires careful due diligence and risk management, but it can significantly improve the company's overall performance. The equity market offers substantial opportunities for growth and value creation.
- Geographic Expansion into Underserved Markets: Expanding its geographic footprint into underserved markets can provide Crescent Capital BDC with access to new investment opportunities and diversify its portfolio. By targeting regions with limited access to capital, FCRX can identify attractive investment opportunities and generate higher returns. This strategy requires careful market research and local expertise, but it can significantly expand the company's growth potential. Emerging markets offer particularly attractive opportunities for investment.
Opportunities
- Increasing demand for capital from middle-market companies.
- Potential for rising interest rates to increase investment yields.
- Expansion into new sectors and geographies.
- Strategic partnerships with private equity firms.
Threats
- Economic downturn could negatively impact portfolio companies.
- Increased competition from other BDCs and alternative lenders.
- Regulatory changes could affect the BDC industry.
- Credit losses on investments in distressed companies.
Competitive Advantages
- Experienced management team with expertise in middle-market lending.
- Established relationships with private equity firms and other capital providers.
- Disciplined investment approach focused on due diligence and risk management.
- Diversified portfolio of investments across various sectors and geographies.
About
Crescent Capital BDC, Inc., formerly known as THL Credit, Inc., is a business development company (BDC) that specializes in providing financing solutions to middle-market companies. The firm's investment strategy centers on direct investments and fund of fund investments, targeting companies seeking capital for growth, acquisitions, market or product expansion, recapitalization, and change of control transactions. Founded with the vision of supporting growing businesses, Crescent Capital BDC strategically avoids investments in start-ups, operationally distressed situations, or companies with speculative business plans, focusing instead on established businesses with proven track records. The company primarily invests in debt securities, including unsecured subordinated or mezzanine debt and second lien secured debt, often incorporating an equity component such as warrants or preferred stock. While debt investments form the core of their portfolio, Crescent Capital BDC also selectively invests in high-yield bonds, private equity, securities of public companies, and securities of non-United States companies. Their investment scope spans diverse sectors, including outsourced business services, healthcare, financials, retailing, media, and consumer discretionary. Crescent Capital BDC typically invests between $10 million and $25 million per transaction, targeting companies with annual revenues ranging from $25 million to $500 million and annual EBITDA between $5 million and $25 million. The firm prefers to take a lead or sole investor role, allowing for greater influence and control over the investment's trajectory. This approach enables Crescent Capital BDC to actively support its portfolio companies and drive value creation.
What They Do
- Invests in debt and equity securities of middle-market companies.
- Provides capital for growth, acquisitions, and recapitalization transactions.
- Focuses primarily on debt securities with potential equity components.
- Targets companies with annual revenues between $25 million and $500 million.
- Invests between $10 million and $25 million per transaction.
- Seeks to be a lead or sole investor in transactions.
- Invests in sectors such as outsourced business services, healthcare, financials, retailing, media, and consumer discretionary.
Business Model
- Generates income from interest payments on debt securities.
- Realizes capital gains from the sale of equity investments.
- Manages a portfolio of investments in middle-market companies.
- Actively supports its portfolio companies to drive value creation.
Industry Context
Crescent Capital BDC operates within the business development company (BDC) sector, which provides capital to small and medium-sized businesses. The BDC industry is influenced by factors such as interest rates, economic growth, and regulatory changes. The market for middle-market lending is estimated to be substantial, with significant demand for capital from companies seeking to grow and expand. Crescent Capital BDC competes with other BDCs such as Ares Capital Corporation (ASIC), BlackRock Capital Investment Corporation (BKCC), Bain Capital Specialty Finance (BCSF), CGBD, and Great Elm Capital Corp (GAINI). These companies compete on the basis of investment strategy, capital availability, and industry expertise.
Key Customers
- Middle-market companies seeking capital for growth and expansion.
- Companies undergoing acquisitions or recapitalization transactions.
- Businesses in sectors such as healthcare, financials, and business services.
- Companies with annual revenues between $25 million and $500 million.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $44M | $8M | $0.23 |
| Q3 2025 | $41M | $7M | $0.19 |
| Q2 2025 | $43M | $15M | $0.41 |
| Q1 2025 | $42M | $4M | $0.11 |
Source: Company filings
Chart & Info
Price Chart
Crescent Capital BDC, Inc. (FCRX) stock price: $25.00 (+0.00, +0.00%)
Why Bull
- •Recent insider buying suggests confidence from management in the company's future prospects, which can positively influence investor sentiment.
- •Community sentiment has shifted towards bullish as discussions around Crescent Capital's growth strategies have gained traction in social forums.
- •Positive news regarding the company's portfolio performance has been circulating, enhancing perceptions of its stability and potential.
- •Increased interest in alternative investments has led to a favorable view of BDCs like Crescent Capital, attracting more retail investors.
Why Bear
- •Concerns about rising interest rates have created anxiety among investors, as BDCs may face tighter margins and reduced profitability.
- •Some community members express skepticism regarding the sustainability of Crescent Capital's recent performance, citing potential market volatility.
- •Recent discussions highlight a lack of significant catalysts that could drive substantial growth in the near term, leading to cautious sentiment.
- •Market perception remains mixed, with some analysts questioning the company's ability to navigate potential economic downturns effectively.
Latest News
-
Crescent Capital BDC, Inc. Reschedules Earnings Release and Conference Call for Fourth Quarter and Fiscal Year Ended December 31, 2025
Yahoo! Finance: FCRX News · Feb 6, 2026
-
Crescent Capital BDC, Inc. Reschedules Earnings Release and Conference Call for Fourth Quarter and Fiscal Year Ended December 31, 2025
GlobeNewswire · Feb 6, 2026
-
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2025 Financial Results
Yahoo! Finance: FCRX News · Feb 4, 2026
-
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2025 Financial Results
GlobeNewswire · Feb 4, 2026
Technical Analysis
Rationale
AI-generated technical analysis for FCRX including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss Crescent Capital BDC, Inc. (FCRX) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for FCRX.
Make a Prediction
Set your price target for Crescent Capital BDC, Inc. (FCRX), choose a timeframe, and track your prediction accuracy.
Current price: $25.00
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FCRX.
Price Targets
Wall Street price target analysis for FCRX.
Insider Flow (30d)
No insider trades in the last 30 days.
MoonshotScore
Score Factors
-
Revenue Growth 2/100
Revenue declined -20.9% YoY, signaling shrinking demand or market headwinds.
-
Gross Margin 8/100
Gross margin at 43.2% indicates good unit economics and healthy profitability per sale.
-
Operating Leverage 4/100
Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.
-
Cash Runway 5/100
Limited cash of $31M could constrain flexibility; watch for dilution risk or debt issuance.
-
R&D Intensity 5/100
R&D spending data is currently unavailable for this company.
-
Insider Activity 6/100
No significant insider buying or selling recently, which is neutral for the stock outlook.
-
Short Interest 2/100
Very low turnover at 0.02% makes this stock illiquid; exiting positions may be difficult.
-
Price Momentum 6/100
Mixed technical signals (above sma50, above sma200); price trend is inconclusive and may consolidate.
-
News Sentiment 5/100
No sentiment data available
What does this score mean?
The MoonshotScore rates FCRX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Crescent Capital BDC, Inc. Reschedules Earnings Release and Conference Call for Fourth Quarter and Fiscal Year Ended December 31, 2025
Crescent Capital BDC, Inc. Reschedules Earnings Release and Conference Call for Fourth Quarter and Fiscal Year Ended December 31, 2025
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2025 Financial Results
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2025 Financial Results
Frequently Asked Questions
What does Crescent Capital BDC, Inc. do?
Crescent Capital BDC, Inc. is a business development company that provides financing solutions to middle-market companies. It invests in debt and equity securities, focusing on companies seeking capital for growth, acquisitions, and recapitalization transactions. The company's investment strategy centers on generating income and capital appreciation through a diversified portfolio of investments in established businesses with proven track records. With a focus on careful due diligence and risk management, Crescent Capital BDC aims to deliver attractive returns to its shareholders while supporting the growth of its portfolio companies.
Is FCRX stock a good buy?
FCRX stock may be a good buy for investors seeking a high dividend yield and exposure to the middle-market lending space. The company's dividend yield of 12.71% is significantly higher than the average dividend yield of the S&P 500. However, investors should also consider the risks associated with investing in a BDC, such as credit risk and interest rate sensitivity. A thorough analysis of the company's financials, portfolio composition, and management team is recommended before making an investment decision. The P/E ratio of 14.82 suggests reasonable valuation, but further analysis is needed.
What are the main risks for FCRX?
The main risks for FCRX include credit risk, interest rate risk, and regulatory risk. Credit risk refers to the possibility that portfolio companies may default on their debt obligations, leading to losses for Crescent Capital BDC. Interest rate risk refers to the sensitivity of the company's investment yields to fluctuations in interest rates. Regulatory risk refers to the potential for changes in regulations governing the BDC industry, which could negatively impact the company's operations and profitability. Additionally, economic downturns could negatively impact portfolio companies.
Is FCRX a good stock to buy?
Whether FCRX is a suitable investment depends on your goals, risk tolerance, and time horizon. Evaluate Crescent Capital BDC, Inc.'s revenue growth, profit margins, debt levels, and valuation relative to peers. This is not financial advice.
What is the FCRX MoonshotScore?
The MoonshotScore rates FCRX from 0 to 100 across growth potential, financial health, market momentum, and risk factors. Scores above 70 suggest strong potential, 50-70 moderate, and below 50 warrants caution. It is recalculated daily using the latest market data. This score is informational only.
How often is FCRX data updated?
FCRX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What do analysts say about FCRX?
Analyst coverage for FCRX includes consensus ratings (buy, hold, sell), 12-month price targets, and earnings estimates from major research firms. Key data points: consensus target price, number of covering analysts, recent upgrades or downgrades, and earnings beat/miss history. See the Analyst Consensus section on this page.
What are the risks of investing in FCRX?
Risk categories for FCRX include market risk, company-specific risk (management, competition), financial risk (debt, cash burn), and macroeconomic risk (rates, inflation). Beta above 1.0 indicates higher volatility than the S&P 500. Review the Risk Factors section on this page for details. All investments carry risk of loss.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Investment decisions should be based on individual risk tolerance and financial circumstances.